Thrivent Financial For Lutherans Adverum Biotechnologies, Inc. Transaction History

Thrivent Financial For Lutherans

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 19, 2021	SELL	$3.36 - $10.56 $221,679 - $696,706	-65,976 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $78,885 - $122,332	-8,519 Reduced 11.44%	65,976 $651,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $149,302 - $216,366	-15,173 Reduced 16.92%	74,495 $808,000
Q3 2020 Nov 10, 2020	BUY	$10.3 - $21.64 $923,580 - $1.94 Million	89,668 New	89,668 $924,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.